(Q36647463)

15 August 2017

1 reference

title

Evolution of artificial cells using nanobiotechnology of hemoglobin based RBC blood substitute as an example (English)

1 reference

15 August 2017

Thomas Ming Swi Chang

series ordinal

1

1 reference

15 August 2017

1 November 2006

1 reference

Artificial Cells, Blood Substitutes, and Biotechnology

15 August 2017

1 reference

15 August 2017

34

1 reference

15 August 2017

6

1 reference

15 August 2017

551-566

1 reference

SEMIPERMEABLE MICROCAPSULES

15 August 2017

1 reference

https://api.crossref.org/works/10.1080%2F10731190600973808

Cell encapsulation: promise and progress

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10731190600973808

The life-sustaining capacity of human polymerized hemoglobin when red cells might be unavailable

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10731190600973808

The use of bovine hemoglobin glutamer-250 (Hemopure) in surgical patients: results of a multicenter, randomized, single-blinded trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10731190600973808

A method for purification and viral inactivation of human placenta hemoglobin

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10731190600973808

Rightshifted dextran-hemoglobin as blood substitute.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10731190600973808

No scavenging and the hypertensive effect of hemoglobin-based blood substitutes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10731190600973808

Oxygen therapeutics: can we tame haemoglobin?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10731190600973808

Nitric oxide scavengers in the treatment of shock associated with systemic inflammatory response syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10731190600973808

Rate of reaction with nitric oxide determines the hypertensive effect of cell-free hemoglobin

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10731190600973808

Fibroblast fiber contraction: role of C and Rho kinase in activation by thromboxane A2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10731190600973808

Polyhemoglobin with different percentage of tetrameric hemoglobin and effects on vasoactivity and electrocardiogram

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10731190600973808

Polyhemoglobin-superoxide dismutase-catalase as a blood substitute with antioxidant properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10731190600973808

In vitro and in vivo effects of polyhaemoglobin-tyrosinase on murine B16F10 melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10731190600973808

Submicron polymer membrane hemoglobin nanocapsules as potential blood substitutes: preparation and characterization

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10731190600973808

10.1080/10731190600973808

21 January 2018

Identifiers

DOI

1 reference

15 August 2017

1 reference

PubMed ID

17090428